Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Indian J Cancer ; 34(2): 73-6, 1997 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9491665

RESUMO

Placental alkaline phosphatase (PLAP) has been shown to be a reliable tumor marker in the management of patients with seminoma. Radioimmunoassay (RIA) and Enzyme linked immunoassay (ELISA) procedures were compared for PLAP levels in serum of seminoma patients. The statistical analysis showed excellent correlationship between the two. It is evident from the results that performance of ELISA in terms of sensitivity specificity, precision, accuracy and reproducibility is equivalent to or better than RIA.


Assuntos
Fosfatase Alcalina/análise , Biomarcadores Tumorais/sangue , Ensaio de Imunoadsorção Enzimática , Placenta/enzimologia , Radioimunoensaio , Seminoma/enzimologia , Neoplasias Testiculares/enzimologia , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Gravidez
2.
Tumori ; 74(2): 171-6, 1988 Apr 30.
Artigo em Inglês | MEDLINE | ID: mdl-3368971

RESUMO

The diagnostic significance of three polyamines (putrescine, spermidine and spermine), of carcinoembryonic antigen and of phosphoglucose isomerase have been compared in sera of patients with breast cancer or benign breast disease and normal age matched controls. The results of the study indicate that the performance of spermine was more striking than that of any of the other markers. The estimation of spermine may prove to be a valuable parameter not only in detection but also in prediction of recurrence of the disease.


Assuntos
Neoplasias da Mama/sangue , Espermina/sangue , Adulto , Doenças Mamárias/sangue , Antígeno Carcinoembrionário/análise , Feminino , Glucose-6-Fosfato Isomerase/sangue , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Putrescina/sangue , Espermidina/sangue
4.
Neoplasma ; 34(3): 305-11, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3302737

RESUMO

TdT (terminal deoxynucleotidyl transferase) can be detected by radio enzymatic assay, biochemical assay in cell extracts, serum or plasma, and intracellularly in the smear by indirect immunofluorescent methods. The IgG fraction of anti-TdT serum is conjugated with fluoresceinisothiocyanate and used directly on the cytospin smears of methanol fixed bone marrow/blood smears. The mice thymocytes and peripheral mononuclear cells of healthy donors were used as positive and negative controls, respectively, for TdT. 64% of our cases of ALL were found to be TdT+. The lymphoblasts of L1 morphology (FAB classification) were more frequently positive for TdT as compared to blasts with L2 morphology. 71% of our cALLa positive blasts in acute lymphoblastic leukemias were TdT+ve as compared to 58% of T-ALL blasts. 75% of PAS positive ALL cases were positive for TdT as well. Only 57% of the cases when acid phosphatase showed unipolar positivity (T type) were positive for TdT. 12% of cases with acute myeloid leukemia (6/47) were TdT+ve and 33% of CML in blastic crisis had TdT+ve blasts. Biochemical assay and IF assay for TdT were in good correlation in our study.


Assuntos
DNA Nucleotidilexotransferase/metabolismo , DNA Nucleotidiltransferases/metabolismo , Leucemia/enzimologia , Medula Óssea/enzimologia , Imunofluorescência , Humanos , Leucemia Linfoide/enzimologia , Leucemia Mieloide/enzimologia , Leucemia Mieloide Aguda/enzimologia , Fenótipo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...